The Current Ratio as of November 2025 (TTM) for DMK Pharmaceuticals Corporation (DMKPQ) is 0.81

According to DMK Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.81. This represents a change of 47.19% compared to the average of 0.55 of the last 4 quarters.

DMK Pharmaceuticals Corporation (DMKPQ) Historical Current Ratio (quarterly & annually)

How has DMKPQ Current Ratio performed in the past?

The mean historical Current Ratio of DMK Pharmaceuticals Corporation over the last ten years is 1.65. The current 0.81 Current Ratio has changed 4.84% with respect to the historical average. Over the past ten years (40 quarters), DMKPQ's Current Ratio was at its highest in in the September 2021 quarter at 4.56. The Current Ratio was at its lowest in in the June 2023 quarter at 0.23.

DMK Pharmaceuticals Corporation (DMKPQ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of DMK Pharmaceuticals Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DMK Pharmaceuticals Corporation (DMKPQ) Average Current Ratio

How has DMKPQ Current Ratio performed in the past?

The current Current Ratio of DMK Pharmaceuticals Corporation (DMKPQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

DMK Pharmaceuticals Corporation (DMKPQ) Current Ratio vs. Peers

How is DMKPQ’s Current Ratio compared to its peers?

DMK Pharmaceuticals Corporation’s Current Ratio is less than IMV Inc. (2.93), greater than BioELife Corp. (0.27), less than Millennium Sustainable Ventures Corp. (0.94), greater than eFFECTOR Therapeutics, Inc. (0.77), less than HLK Biotech Holding Group, Inc. (0), less than ContraFect Corporation (0.85), less than BIMI International Medical Inc. (0.92), less than Minerva Surgical, Inc. (2.53), greater than American Medical Technologies Inc. (0.49), greater than Omnimmune Holdings, Inc. (0.01),

Build a custom stock screener for DMK Pharmaceuticals Corporation (DMKPQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DMK Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DMK Pharmaceuticals Corporation (DMKPQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DMK Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.